Puma Biotechnology (PBYI)
(Delayed Data from NSDQ)
$2.54 USD
+0.10 (4.10%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $2.54 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth A Momentum A VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/07/2024
Time: -- |
9/2024 | $0.30 | 25.28% |
Earnings Summary
For their last quarter, Puma Biotechnology (PBYI) reported earnings of -$0.05 per share, beating the Zacks Consensus Estimate of $-0.10 per share. This reflects a positive earnings surprise of 50.00%. Look out for PBYI's next earnings release expected on November 07, 2024. For the next earning release, we expect the company to report earnings of $0.30 per share, reflecting a year-over-year increase of 76.47%.
Earnings History
Price & Consensus
Zacks News for PBYI
Zacks.com featured highlights Abercrombie & Fitch, Puma Biotechnology, Spotify and Oddity
PBYI: What are Zacks experts saying now?
Zacks Private Portfolio Services